Research Reports
Explore our comprehensive catalog of market intelligence across 60+ industries
Showing 1 to 10 of 10 reports
Precision Medicine and Genomic Testing: Personalized Treatment Trends
Genomic sequencing volume reached 12.8M tests globally in 2024, growing 34% YoY as costs declined to $400-800 per whole genome. Companion diagnostic t...
Dr. Jennifer Park
Feb 25, 2025
Regenerative Medicine and Tissue Engineering: Scaffold and Cell Technologies
Regenerative medicine market reached $48.2B in 2024 with regenerative cell therapies capturing 31% of market. Tissue engineering scaffolds and decellu...
Dr. Thomas Bergmann
Feb 15, 2025
Biomarkers and Diagnostics: Early Disease Detection and Monitoring
Liquid biopsy tests for early cancer detection achieved 92% sensitivity for stage I cancers in clinical trials by 2024. Biomarker discovery using prot...
Dr. Elena Rodriguez
Feb 10, 2025
Monoclonal Antibodies: Target Expansion and Manufacturing Innovation
Monoclonal antibody (mAb) market reached $185B by 2024 with bispecific antibodies capturing 18% of new launches. mAb manufacturing capacity exceeded 2...
Dr. Hiroshi Sato
Jan 25, 2025
Cell and Gene Therapy: Manufacturing Scale-Up and Clinical Progress
Cell and gene therapy approvals reached 18 new medicines in 2024 with manufacturing capacity constraints limiting patient access. CAR-T cell therapy m...
Dr. Klaus Mueller
Jan 20, 2025
CRISPR and Gene Editing: Therapeutic Development and Ethics
CRISPR-based therapies in clinical development reached 120 programs by 2024. Base editing and prime editing approaches advanced toward clinical transl...
Dr. Sarah Chen
Jan 08, 2025
Synthetic Biology and Engineered Biology: Commercial Applications
Synthetic biology platforms funding reached $4.2B in 2024 with applications emerging in biofuels, biomaterials, and therapeutics. Engineered microorga...
Dr. Aisha Kumar
Dec 22, 2024
Immunotherapy and Cancer Vaccines: Therapeutic Landscape Evolution
Immunotherapy adoption reached 68% of metastatic cancer patients in developed markets by 2024. Checkpoint inhibitor market reached $68B with combinati...
Dr. Anna Bergstrom
Dec 05, 2024
Microbiome and Probiotics: Therapeutic and Functional Food Applications
Microbiome-based therapeutic development reached 240 clinical programs by 2024. Probiotic and prebiotic food and supplement market reached $102B globa...
Dr. Patrick Murphy
Nov 15, 2024
RNA Therapeutics: mRNA, siRNA, and Antisense Technology Expansion
RNA therapeutic platforms expanded beyond infectious disease with cancer, genetic disease, and protein replacement applications advancing in clinical ...
Dr. Louise Dupont
Nov 08, 2024